Relafen 750, pharmacologically known as naproxen, represents a fascinating case study within the biochemical area and showcases the power of targeted inflammation management. Its mechanism of action centers on the inhibition of cyclooxygenase proteins, specifically COX-2, decreasing the synthesis of prostaglandins – key instigators in the inflam… Read More

Relafen 750, chemically known as naproxen sodium , offers a unique physiological pathway of action. From a pharmaceutical angle , it functions primarily as a NSAID agent , inhibiting cyclooxygenase enzymes – notably COX-1 and COX-2 – to reduce pain and discomfort. The ensuing decrease in inflammatory mediator synthesis impacts a broad spectrum … Read More